<?xml version="1.0"?><rdf:RDF xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:edm="http://www.europeana.eu/schemas/edm/" xmlns:wgs84_pos="http://www.w3.org/2003/01/geo/wgs84_pos" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:rdaGr2="http://rdvocab.info/ElementsGr2" xmlns:oai="http://www.openarchives.org/OAI/2.0/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:ore="http://www.openarchives.org/ore/terms/" xmlns:skos="http://www.w3.org/2004/02/skos/core#" xmlns:dcterms="http://purl.org/dc/terms/"><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-MAL3DJ1I/8fb51b5f-5adc-4245-92d3-276b07a53e51/HTML"><dcterms:extent>67 KB</dcterms:extent></edm:WebResource><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-MAL3DJ1I/3025f3fd-7776-41f5-8b58-f3103d7bca41/PDF"><dcterms:extent>162 KB</dcterms:extent></edm:WebResource><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-MAL3DJ1I/24b555c8-c435-468c-8d4a-37e8fa7e6dd7/TEXT"><dcterms:extent>37 KB</dcterms:extent></edm:WebResource><edm:TimeSpan rdf:about="1992-2025"><edm:begin xml:lang="en">1992</edm:begin><edm:end xml:lang="en">2025</edm:end></edm:TimeSpan><edm:ProvidedCHO rdf:about="URN:NBN:SI:doc-MAL3DJ1I"><dcterms:isPartOf rdf:resource="https://www.dlib.si/details/URN:NBN:SI:spr-FNIFVE9S" /><dcterms:issued>2002</dcterms:issued><dc:creator>Plevová, Pavlina</dc:creator><dc:format xml:lang="sl">11 strani</dc:format><dc:format xml:lang="sl">številka:2</dc:format><dc:format xml:lang="sl">letnik:36</dc:format><dc:format xml:lang="sl">str. 109-119</dc:format><dc:identifier>ISSN:1318-2099</dc:identifier><dc:identifier>COBISSID:15188697</dc:identifier><dc:identifier>URN:URN:NBN:SI:doc-MAL3DJ1I</dc:identifier><dc:language>en</dc:language><dc:publisher xml:lang="sl">Association of Radiology and Oncology</dc:publisher><dcterms:isPartOf xml:lang="sl">Radiology and oncology (Ljubljana)</dcterms:isPartOf><dc:subject xml:lang="en">Adverse effects</dc:subject><dc:subject xml:lang="en">Antineoplastic agents</dc:subject><dc:subject xml:lang="sl">Antineoplastiki</dc:subject><dc:subject xml:lang="sl">Celična adhezija, molekule</dc:subject><dc:subject xml:lang="en">Cell adhesion molecules</dc:subject><dc:subject xml:lang="sl">Citokini</dc:subject><dc:subject xml:lang="en">Cytokines</dc:subject><dc:subject xml:lang="en">Drug effects</dc:subject><dc:subject xml:lang="sl">kemoterapija</dc:subject><dc:subject xml:lang="sl">onkologija</dc:subject><dc:subject xml:lang="sl">poškodbe tkiva</dc:subject><dc:subject xml:lang="en">Radiation effects</dc:subject><dc:subject xml:lang="sl">radioterapija</dc:subject><dc:subject xml:lang="en">therapy</dc:subject><dc:subject xml:lang="sl">zdravljenje</dc:subject><dcterms:temporal rdf:resource="1992-2025" /><dc:title xml:lang="sl">Radiotherapy- and chemotherapy-induced normal tissue damage| the role of cytokines and adhesion molecules|</dc:title><dc:description xml:lang="sl">Background. lonising radiation and cytostatic agents used in cancer therapy exert damaging effects on normal tissues and induce a complex response at the cellular and molecular levels. Cytokines and adhesion molecules are involved in this response. Methods. Published data on the given topic have been reviewed. Results and conclusions. Various cytokines and adhesion molecules, including tumor necrosis factor a, interleukins-1,-2,-4, and -6, interferon gamma, granulocyte macrophage- and macrophage- colony stimulating factors, transforming growth factor beta, platelet-derived growth factor, insulin-like growth factor 1, fibroblast and epidermal growth factors, platelet-activating factor, intercellular adhesion molecule-1, vascular cell adhesion molecule-1, E- and P-selectins are involved in the response of normal tissues to ionizing radiation- and chemotherapy-induced normal tissues damage and are co-responsible for some side effects of these treatment modalities, including fever, anorexia and fatigue, suppression of hematopoiesis, both acute and latelocal tissue response</dc:description><dc:description xml:lang="sl">Ozadje. Ionizirajoče sevanje in citostatiki, ki jih uporabljamo za zdravljenjeraka, poškodujejo normalno tkivo in sprožijo celovit odgovor tako na celularni kot molekularni ravni, vanj pa so vpleteni tudi citokini in adhezijske molekule. Metode. Zbrali in pregledali smo že objavljene podatke. Rezultai in zaključki. Različni citokini in adhezjske molekule, kot so nekrotizirajoči faktor alfa interleukini 1, 2, 4 in 6, intereferon gama, granulocite in makrofage stimulirajoči faktor, transformirajoči rastni faktor beta, faktor aktiviranja krvnih ploščic, intercelična adhezijka molekula 1, vaskularno-celična adhezijska molekula- 1, in selektini E in P so vpleteni v odgovor normalnega tkiva na zdravljenje z ionozirajočim sevanjem in kemoterapijo in so odgovorni za poškodbe tkiva zaradi zdravljenja ter nezaželenih učinkov teh načinov zdravljenja, na primer vročine, anoreksije, utrujenosti, zaviranja hematopoeze ter akutnega in poznega lokalnega odziva nazdravljenje</dc:description><edm:type>TEXT</edm:type><dc:type xml:lang="sl">znanstveno časopisje</dc:type><dc:type xml:lang="en">journals</dc:type><dc:type rdf:resource="http://www.wikidata.org/entity/Q361785" /></edm:ProvidedCHO><ore:Aggregation rdf:about="http://www.dlib.si/?URN=URN:NBN:SI:doc-MAL3DJ1I"><edm:aggregatedCHO rdf:resource="URN:NBN:SI:doc-MAL3DJ1I" /><edm:isShownBy rdf:resource="http://www.dlib.si/stream/URN:NBN:SI:doc-MAL3DJ1I/3025f3fd-7776-41f5-8b58-f3103d7bca41/PDF" /><edm:rights rdf:resource="http://creativecommons.org/licenses/by/4.0/" /><edm:provider>Slovenian National E-content Aggregator</edm:provider><edm:intermediateProvider xml:lang="en">National and University Library of Slovenia</edm:intermediateProvider><edm:dataProvider xml:lang="sl">Društvo radiologije in onkologije</edm:dataProvider><edm:object rdf:resource="http://www.dlib.si/streamdb/URN:NBN:SI:doc-MAL3DJ1I/maxi/edm" /><edm:isShownAt rdf:resource="http://www.dlib.si/details/URN:NBN:SI:doc-MAL3DJ1I" /></ore:Aggregation></rdf:RDF>